126 related articles for article (PubMed ID: 1507198)
21. Specificity of the wound-induced leucine aminopeptidase (LAP-A) of tomato activity on dipeptide and tripeptide substrates.
Gu YQ; Walling LL
Eur J Biochem; 2000 Feb; 267(4):1178-87. PubMed ID: 10672029
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
23. Conformation and inhibitory properties of peptides based on the tissue kallikrein-aprotinin complex.
Deshpande MS; Boylan J; Hamilton JA; Burton J
Int J Pept Protein Res; 1991 Jun; 37(6):536-43. PubMed ID: 1717392
[TBL] [Abstract][Full Text] [Related]
24. Individual reaction steps in the release of kallidin from kininogen by tissue kallikrein.
Fiedler F; Hinz H; Lottspeich F
Adv Exp Med Biol; 1986; 198 Pt A():283-9. PubMed ID: 3643712
[TBL] [Abstract][Full Text] [Related]
25. Cysteine proteinase inhibitor in the ascitic fluid of sarcoma 180 tumor-bearing mice is a low molecular weight kininogen. Partial NH2- and COOH-terminal sequences and susceptibility to various glandular kallikreins.
Sueyoshi T; Uwani M; Itoh N; Okamoto H; Muta T; Tokunaga F; Takada K; Iwanaga S
J Biol Chem; 1990 Jun; 265(17):10030-5. PubMed ID: 2351646
[TBL] [Abstract][Full Text] [Related]
26. Tetrapeptide substrates for the discrimination among kallikreins and other trypsin-like serine proteinases.
Prado ES; Araújo-Viel MS; Juliano MA; Juliano L; Stella RC; Sampaio CA
Biol Chem Hoppe Seyler; 1986 Mar; 367(3):199-205. PubMed ID: 3518738
[TBL] [Abstract][Full Text] [Related]
27. Studies on the primary structure of bovine high-molecular-weight kininogen. Amino acid sequence of a fragment ("histidine-rich peptide") released by plasma kallikrein.
Han YN; Komiya M; Iwanaga S; Suzuki T
J Biochem; 1975 Jan; 77(1?):55-68. PubMed ID: 1169237
[TBL] [Abstract][Full Text] [Related]
28. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.
Chen VC; Chao L; Chao J
J Biol Chem; 2000 Dec; 275(49):38457-66. PubMed ID: 10993887
[TBL] [Abstract][Full Text] [Related]
29. Template-assisted rational design of peptide inhibitors of furin using the lysine fragment of the mung bean trypsin inhibitor.
Tao H; Zhang Z; Shi J; Shao XX; Cui D; Chi CW
FEBS J; 2006 Sep; 273(17):3907-14. PubMed ID: 16934032
[TBL] [Abstract][Full Text] [Related]
30. Design of kallidin-releasing tissue kallikrein inhibitors based on the specificities of the enzyme's binding subsites.
Portaro FC; Cezari MH; Juliano MA; Juliano L; Walmsley AR; Prado ES
Biochem J; 1997 Apr; 323 ( Pt 1)(Pt 1):167-71. PubMed ID: 9173877
[TBL] [Abstract][Full Text] [Related]
31. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
33. Cleavage of human kininogen fragments at Met-Lys by human tissue kallikrein.
Sueiras-Diaz J; Jones DM; Ashworth D; Horton J; Evans DM; Szelke M
Braz J Med Biol Res; 1994 Aug; 27(8):1935-42. PubMed ID: 7749384
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a new kallikrein-like enzyme (KLP-S3) of the rat submandibular gland.
Berg T; Schøyen H; Wassdal I; Hull R; Gerskowitch VP; Toft K
Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):819-28. PubMed ID: 1536657
[TBL] [Abstract][Full Text] [Related]
35. Homology modelling of rat kallikrein rK9, a member of the tissue kallikrein family: implications for substrate specificity and inhibitor binding.
Moreau T; Gauthier F
Protein Eng; 1996 Nov; 9(11):987-95. PubMed ID: 8961351
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins.
Kato H; Enjyoji K; Miyata T; Hayashi I; Oh-ishi S; Iwanaga S
Biochem Biophys Res Commun; 1985 Feb; 127(1):289-95. PubMed ID: 3844939
[TBL] [Abstract][Full Text] [Related]
37. Chromogenic substrates of bovine beta-trypsin: the influence of an amino acid residue in P1 position on their interaction with the enzyme.
Lesner A; Kupryszewski G; Rolka K
Biochem Biophys Res Commun; 2001 Aug; 285(5):1350-3. PubMed ID: 11478806
[TBL] [Abstract][Full Text] [Related]
38. Substrate specificity and kinetic properties of pepstatin-insensitive carboxyl proteinase from Pseudomonas sp. No. 101.
Oda K; Nakatani H; Dunn BM
Biochim Biophys Acta; 1992 Apr; 1120(2):208-14. PubMed ID: 1562589
[TBL] [Abstract][Full Text] [Related]
39. Rational design and selection of bivalent peptide ligands of thrombin incorporating P4-P1 tetrapeptide sequences: from good substrates to potent inhibitors.
Su Z; Vinogradova A; Koutychenko A; Tolkatchev D; Ni F
Protein Eng Des Sel; 2004 Aug; 17(8):647-57. PubMed ID: 15358856
[TBL] [Abstract][Full Text] [Related]
40. Calorimetric and spectroscopic examination of the solution phase structures of prekallikrein binding domain peptides of high molecular weight kininogen.
You JL; Scarsdale JN; Harris RB
J Protein Chem; 1991 Jun; 10(3):301-11. PubMed ID: 1910462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
